National Academies report recommends greater transparency, collaboration between regulatory agencies

A report by the National Academies of Sciences, Engineering and Medicine recommends that FDA, EMA and other drug regulatory agencies tear down walls that limit information sharing and increase collaboration in order to avoid redundant regulatory